Source: Annual Congress 2006 - Infections in immunocompromised patients
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
R. Maekura, Y. Nishiuchi, S. Kitada, A. Tamaru, M. Ito (Toyonaka, Osaka, Japan). Residential bathroom is a candidate for source of pulmonary mycobacterium avium complex infection. Eur Respir J 2006; 28: Suppl. 50, 3209

Member's Comments

No comment yet.

Related content which might interest you: Sentinel-site surveillance of Mycobacterium avium complex pulmonary disease Source: Eur Respir J 2005; 26: 1092-1096 Year: 2005 Mycobacterium tuberculosis (MTB) content in the air of in-patient facility for the management of pulmonary tuberculosis (TB) Source: Eur Respir J 2001; 18: Suppl. 33, 340s Year: 2001 No human transmission of Mycobacterium malmoense in a perfect storm setting Source: Eur Respir J 2012; 40: 1576-1578 Year: 2012 Human-to-human transmission of Mycobacterium kansasii or victims of a shared source? Source: Eur Respir J 2014; 44: 1085-1087 Year: 2014 Chronic pulmonary disease with Mycobacterium abscessus complex is a biofilm infection Source: Eur Respir J 2015; 46: 1823-1826 Year: 2015 Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments Source: Eur Respir Rev, 31 (163) 210212; 10.1183/16000617.0212-2021 Year: 2022 Clinical relevance of differentiation between Mycobacterium avium and M. intracellulare in M. avium complex pulmonary disease in Croatia Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities Year: 2019 Risk factors for Mycobacterium tuberculosis infection among contacts of pulmonary tuberculosis patients Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I Year: 2012 Importance of identifying Mycobacterium bovis as a causative agent of human tuberculosis Source: Eur Respir J 2010; 35: 692-694 Year: 2010 Clinical features of pulmonary Mycobacterium avium intracellulare complex disease with a solitary pulmonary nodule in Japan Source: Eur Respir J 2005; 26: Suppl. 49, 687s Year: 2005 Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019 The utility of a serodiagnosis for mycobacterium avium complex pulmonary disease diagnosed by the single available bronchial wash Source: Eur Respir J 2004; 24: Suppl. 48, 206s Year: 2004 Pulmonary diseases caused by non-tuberculous mycobacteria Source: Eur Respir Mon 2012; 58: 25-37 Year: 2012 Serodiagnosis of Mycobacterium avium complex pulmonary disease in the USA Source: Eur Respir J 2013; 42: 454-460 Year: 2013 Nontuberculous mycobacterial infections Source: Eur Respir Mon 2011; 52: 115-129 Year: 2011 Antibody testing for Mycobacterium avium complex infection in cystic fibrosis patients Source: International Congress 2018 – Cystic fibrosis: microbiological aspects and new treatments Year: 2018 Discriminating active from latent tuberculosis by Mycobacterium tuberculosis (MTB)-peptide specific immunoresponses Source: Annual Congress 2008 - Priorities for tuberculosis research in Europe: discussing the results of the Tuberculosis Network European Trials Group (TBNET) Year: 2008 Isolation of M. abscessus from patients with M. avium complex (MAC) lung disease Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013 Investigation of the inhibition of adherence of Mycobacterium avium complex (MAC) and Mycobacterium tuberculosis (MTB) to the respiratory mucosa Source: Eur Respir J 2001; 18: Suppl. 33, 480s Year: 2001 Mycobacterium avium complex infection: phenotypes and outcomes Source: Eur Respir J, 50 (3) 1701380; 10.1183/13993003.01380-2017 Year: 2017